512 results
SC 14D9
CTIC
CTI BioPharma Corp
25 May 23
Tender offer solicitation
7:00am
with the Transactions), (ii) reimbursement for COBRA premiums for up to eighteen (18) months, (iii) reimbursement for life insurance premiums for eighteen (18 … ; (iii) reimbursement for up to twelve (12) months for COBRA premiums to continue his medical coverage and that of his eligible dependents; (iv
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
limit the Company’s indemnity and reimbursement obligations to the extent such indirect or consequential losses or damages are included in any third
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
, the reliability of any debt or equity funding commitments, any termination or breakup fees, expense reimbursement provisions and any conditions … and Head of US Operations at UCB, Vice President & General Manager, Value, Access, Reimbursement and Patient Experience at Amgen, Chief Operating Officer
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
or consequential losses or damages provided that nothing contained in this sentence shall limit the Company’s indemnity and reimbursement obligations
SC14D9C
EX-2.1
9bcwh 8lexc
10 May 23
Written communication relating to third party tender offer
1:30pm
8-K
EX-2.1
eow00eo37v n5
10 May 23
Tender and Support Agreement
8:05am
8-K
EX-99.1
1rbg0knb57ltnq7 z4l0
28 Sep 22
Other Events
4:05pm
S-8
o3ua2zy12 ax1m8t6
16 Jun 22
Registration of securities for employees
4:18pm
8-K
EX-10.1
g0gn6x68418
3 Jun 22
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.2
bt083te88e1g3
3 Jun 22
Departure of Directors or Certain Officers
4:06pm
8-K
tpcn yviyfgqsw
4 Mar 22
Departure of Directors or Certain Officers
5:04pm
8-K
EX-10.2
xu3q4
4 Mar 22
Departure of Directors or Certain Officers
5:04pm